Position in MRK
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$6,654,244
+$4,531,246 QoQ
Shares Held
51,784
+193.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#915
of 3,769 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 46%
Shared 0%
None 54%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $87,152,887 across 10 Drug Manufacturers - General names. MRK ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,531 | $31,822,079 | |
| 2 | ABBV |
AbbVie Inc.
|
85,535 | $21,524,027 | |
| 3 | JNJ |
Johnson & Johnson
|
43,298 | $10,996,393 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
59,347 | $7,497,899 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
51,784 | $6,654,244 | |
| 6 | AMGN |
Amgen Inc
|
15,621 | $5,656,676 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,475 | $1,006,909 | |
| 8 | PFE |
Pfizer Inc
|
40,733 | $980,850 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,654,244 | 51,784 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,122,998 | 17,649 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,461,008 | 13,880 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,187,525 | 14,149 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $933,296 | 11,790 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,244,163 | 13,861 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,230,667 | 12,371 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,394,516 | 12,280 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,225,620 | 9,900 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,201,008 | 9,102 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,018,464 | 9,342 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $950,228 | 9,230 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,094,589 | 9,486 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $351,618 | 3,305 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $323,419 | 2,915 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $302,281 | 3,510 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $863,562 | 9,472 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $509,858 | 6,214 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $356,452 | 4,651 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $392,299 | 5,223 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $234,045 | 3,036 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $246,545 | 3,014 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $245,366 | 2,958 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $248,384 | 3,212 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||